Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray

Molecular and Cellular Biochemistry

Volumn 347, Issue 1-2, 2011, Pages 117-125

  Shi, Weidong ^a   Meng, Zhiqiang ^a   Chen, Zhen ^a   Luo, Jianmin ^b   Liu, Luming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Antibody microarray; Cell line; Liver metastasis; Pancreatic cancer; Proteomic analysis

Indexed keywords

CD34 ANTIBODY; CLAUDIN 5; CULLIN; CYTOKERATIN 18; CYTOKERATIN 7; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; GLUCAGON; INTERLEUKIN 10; INTERLEUKIN 17; MATRIX METALLOPROTEINASE 19; MOESIN; PROLACTIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; ENZYME REGULATION; HUMAN; HUMAN CELL; LIVER METASTASIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIBODIES, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEIN TRANSPORT; PROTEOME; PROTEOMICS; SUBCELLULAR FRACTIONS;

EID: 78651302578     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0619-y     Document Type: Article

References (37)

1. C Ru P Sheng A Teresa A Ruedi Brentnall 2005 Proteomic profiling of pancreatic cancer for biomarker discovery Mol Cell Proteomics 4 523 533 10.1074/mcp.R500004-MCP200 (Pubitemid 40590569)
2. J Ingvarsson C Wingren A Carlsson P Ellmark B Wahren G Engström U Harmenberg M Krogh C Peterson CK Borrebaeck 2008 Detection of pancreatic cancer using antibody microarray-based serum protein profiling Proteomics 8 2211 2219 1:CAS:528:DC%2BD1cXotVeitLc%3D 10.1002/pmic.200701167 18528842 (Pubitemid 351898027)
3. R Orchekowski D Hamelinck L Li E Gliwa M Van Brocklin JA Marrero GF Vande Woude ZD Feng R Brand BB Brand 2005 Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer Cancer Res 65 193 202 10.1158/0008-5472.CAN-05-1436 (Pubitemid 41713391)
4. D Vimalachandran E Costello 2004 Proteomic technologies and their application to pancreatic cancer Expert Rev Proteomics 4 493 501 10.1586/14789450.1.4.493 (Pubitemid 43826414)
5. AR Shekouh CC Thompson W Prime F Campbell J Hamlett CS Herrington NR Lemoine T Crnogorac-Jurcevic MW Buechler H Friess JP Neoptolemos SR Pennington E Costello 2003 Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma Proteomics 3 1988 2001 1:CAS:528:DC%2BD3sXosFOnur0%3D 10.1002/pmic.200300466 14625861 (Pubitemid 37305893)
6. JJ Shen MD Person JJ Zhu JL Abbruzzese DH Li 2004 Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry Cancer Res 64 9018 9026 1:CAS:528:DC%2BD2cXhtVOmsLjP 10.1158/0008-5472.CAN-04-3262 15604267 (Pubitemid 39665512)
7. WD Shi ZQ Meng Z Chen JH Lin ZH Zhou LM Liu 2009 Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis Cancer Lett 283 84 91 1:CAS:528:DC%2BD1MXoslSjtLo%3D 10.1016/j.canlet.2009.03.030 19375852
8. SP Gygi Y Rochon BR Franza R Aebersold 1999 Correlation between protein and mRNA abundance in yeast Mol Cell Biol 19 1720 1730 1:CAS:528: DyaK1MXhsFeqtrc%3D 10022859
9. M Ahram CJ Best MJ Flaig JW Gillespie IM Leiva RF Chuaqui G Zhou H Shu PH Duray WM Linehan M Raffeld DK Ornstein Y Zhao EF Petricoin III MR Emmert-Buck 2002 Proteomic analysis of human prostate cancer Mol Carcinog 33 9 15 1:CAS:528:DC%2BD38Xmt1yjtg%3D%3D 10.1002/mc.10019 11807953 (Pubitemid 34052302)
10. PA Everley J Krijgsveld BR Zetter SP Gygi 2004 Quantitative cancer proteomics, stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research Mol Cell Proteomics 3 729 735 1:CAS:528:DC%2BD2cXlvFensL4%3D 10.1074/mcp.M400021-MCP200 15102926 (Pubitemid 39077003)
11. BB Haab 2005 Antibody arrays in cancer research Mol Cell Proteomics 4 377 383 1:CAS:528:DC%2BD2MXjtFCis7c%3D 10.1074/mcp.M500010-MCP200 15671041 (Pubitemid 40590557)
12. IM Ghobrial DJ McCormick SH Kaufmann AA Leontovich DA Loegering NT Dai KL Krajnik MJ Stenson MF Melhem AJ Novak SM Ansell TE Witzig 2005 Proteomic analysis of mantle-cell lymphoma by protein microarray Blood 105 3722 3730 1:CAS:528:DC%2BD2MXjvFejtLg%3D 10.1182/blood-2004-10-3999 15650054 (Pubitemid 40628222)
13. G Poschmann B Sitek B Sipos M Hamacher O Vonend HE Meyer K Stühler 2009 Cell-based proteome analysis: the first stage in the pipeline for biomarker discovery Biochim Biophys Acta 1794 1309 1316 1:CAS:528:DC%2BD1MXhtV2kt7rI 19595794
14. N Chen W Sun XY Deng YW Hao XL Chen BC Xing W Jia J Ma HD Wei YP Zhu XH Qian Y Jiang FC He 2008 Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC Proteomics 8 5108 5118 1:CAS:528:DC%2BD1MXlsFentQ%3D%3D 10.1002/pmic.200800280 19016532
15. YF Hou ST Yuan HC Li J Wu JS Lu G Liu LJ Lu ZZ Shen J Ding ZM Shao 2004 ERbeta exerts multiple stimulative effects on human breast carcinoma cells Oncogene 23 5799 5806 1:CAS:528:DC%2BD2cXmtVCnsLs%3D 10.1038/sj.onc.1207765 15208676 (Pubitemid 39093025)
16. SJ Ding Y Li YX Tan MR Jiang B Tian YK Liu XX Shao SL Ye JR Wu R Zeng HY Wang ZY Tang QX Xia 2004 From proteomic analysis to clinical significance Mol Cell Proteomics 3 73 81 1:CAS:528:DC%2BD2cXhtVantLs%3D 14593079
17. E Missiaglia E Blaveri B Terris YH Wang EC Costello JP Neoptolemos T Crnogorac-Jurcevic NR Lemoine 2004 Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis Int J Cancer 112 100 112 1:CAS:528:DC%2BD2cXnvVWlsbc%3D 10.1002/ijc.20376 15305381 (Pubitemid 39249497)
18. T Sakaguchi S Suzuki H Higashi K Inaba S Nakamura S Baba T Kato H Konno 2008 Expression of tight junction protein Claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma J Surg Res 147 123 131 1:CAS:528:DC%2BD1cXlslaitLk%3D 10.1016/j.jss.2007.07.013 17981296 (Pubitemid 351626080)
19. J Madoz-Gurpide M Canamero LS Jose Solano P Alfonso J Ignacio Casal 2007 A proteomics analysis of cell signaling alterations in colorectal cancer Mol Cell Proteomics 6 2150 2164 1:CAS:528:DC%2BD1cXksF2itQ%3D%3D 10.1074/mcp.M700006-MCP200 17848589
20. JR Jessen 2009 Noncanonical Wnt signaling in tumor progression and metastasis Zebrafish 6 21 28 1:CAS:528:DC%2BD1MXkvVGmtrY%3D 10.1089/zeb.2008. 0571 19292672
21. SL Lai AJ Chien RT Moon 2009 Wnt/Fz signaling, the cytoskeleton potential roles in tumorigenesis Cell Res 19 532 545 1:CAS:528:DC%2BD1MXlsFKrt7g%3D 10.1038/cr.2009.41 19365405
22. PH Thaker K Yokoi NB Jennings Y Li RB Rebhun Jr DL Rousseau D Fan AK Sood 2005 Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist Nembutal Cancer Biol Ther 4 753 758 1:CAS:528:DC%2BD28XjtlWktb4%3D 10.4161/cbt.4.7.1827 15970706
23. A Couvelard JT Hu G Steers D Otoole A Sauvanet J Belghiti P Bedossa K Gatter P Ruszniewski F Pezzella 2006 Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors Gastroenterology 131 1597 1610 1:CAS:528:DC%2BD28Xhtlant77I 10.1053/j.gastro. 2006.09.007 17064702 (Pubitemid 44780863)
24. GP Chen N Shukeir A Potti K Sircar A Aprikian D Goltzman SA Rabbani 2004 Up-regulation of Wnt-1 and β-Catenin production in patients with advanced metastatic prostate carcinoma Cancer 15 1345 1356 10.1002/cncr.20518 (Pubitemid 39180390)
25. JS Palumbo KA Barney EA Blevins MA Shaw A Mishra MJ Flick KW Kombrinck KE Talmage M Souri A Ichinose JL Degen 2008 Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function J Thromb Haemost 6 812 819 1:CAS:528:DC%2BD1cXntVOls78%3D 10.1111/j.1538-7836.2008.02938.x 18315549 (Pubitemid 351524542)
26. I Macikova A Perzelova P Mraz J Steno I Bizik 2001 Establishment, morphological, growth and cytoskeletal properties of 135-BCA carcinoma cell line derived from lung brain metastasis Neoplasma 6 479 482
27. I Kryczek S Wei W Szeliga LH Vatan WP Zou 2009 Endogenous IL-17 contributes to reduced tumor growth and metastasis Blood 114 357 359 1:CAS:528:DC%2BD1MXovVKlsr0%3D 10.1182/blood-2008-09-177360 19289853
28. S Varghese M Burness H Xu T Beresnev J Pingpank HR Alexander 2007 Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum Ann Surg Oncol 14 3460 3471 10.1245/s10434-007-9557-7 17899288 (Pubitemid 350160124)
29. S Mocellin F Marincola CR Rossi D Nitti M Lise 2004 The multifaceted relationship between IL-10 and adaptative immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61 76 1:CAS:528:DC%2BD2cXmvFKktQ%3D%3D 10.1016/j.cytogfr.2003.11.001 14746814 (Pubitemid 38121291)
30. S Shinji Z Naito T Ishiwata TN Anaka K Furukawa H Suzuki T Seya H Kan H Tsuruta S Matsumoto A Matsuda N Teranishi Y Ohaki T Tajiri 2006 Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis Int J Oncol 29 357 364 1:CAS:528: DC%2BD28XotFKmu78%3D 16820877
31. Y Morimoto H Kurokawa T Tanaka Y Yamashita S Kito S Okabe T Takahashi T Ohba 2006 Correlation between the incidence of central nodal necrosis in cervical lymph node metastasis and the extent of differentiation in oral squamous cell carcinoma Dentomaxillofacial Radiol 35 18 23 1:STN:280: DC%2BD28%2Fjt12gug%3D%3D 10.1259/dmfr/24536918 (Pubitemid 43235462)
32. A Kolb S Rieder D Born NA Giese T Giese G Rudofsky J Werner MW Buchler H Friess I Esposito J Kleeff 2009 Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus Cancer Biol Ther 13 8 16
33. P Lissoni A Bignami L Frontini V Manganini E Dapretto GS Gardani P Vigano G Strada 2005 Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer Int J Biol Markers 20 123 125 1:CAS:528: DC%2BD2MXpsFektrk%3D 16011043
34. A Dagvadorj S Collins JB Jomain J Abdulghani J Karras T Zellweger H Li M Nurmi K Alanen T Mirtti T Visakorpi L Bubendorf V Goffin MT Nevalainen 2007 Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway Endocrinology 148 3089 3101 1:CAS:528:DC%2BD2sXntVOgurs%3D 10.1210/en.2006-1761 17412813 (Pubitemid 46996970)
35. M Gronborg TZ Kristiansen A Iwahori R Chang R Reddy N Sato H Molina ON Jensen RH Hruban MG Goggins A Maitra A Pandey 2006 Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol Cell Proteomics 5 157 171 1:CAS:528:DC%2BD28Xms1aqsg%3D%3D 16215274
36. HY Kenneth KR Anil AB Ian 2005 Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry J Proteome Res 4 1742 1751 10.1021/pr050174l (Pubitemid 41464802)
37. ZL Sun Y Zhu FQ Wang R Chen T Peng ZN Fan ZK Xu Y Miao 2007 Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers Biochim Biophys Acta 1774 764 771 1:CAS:528:DC%2BD2sXmt1yhs70%3D 17507299